title: Chemonucleolysis.
abstract: In November 1982, the Federal Drug Administration approved Chymodiactin, chymopapain in injection form, for the treatment of herniated intervertebral discs. This procedure, termed chemonucleolysis, requires radiologic support. This article describes the anatomy, pathology, and special techniques related to chemonucleolysis and defines the role of the radiologic technologist in the completion of this procedure.
authors.affiliation: Radiation Oncology Administration, University of Cincinnati Hospital, Ohio 45267-0757.
authors.forename: J
authors.initials: J
authors.lastname: Fodor
authors.forename: J C
authors.initials: JC
authors.lastname: Malott
mesh_terms: D002917:Chymopapain / Q000627:therapeutic use; D005471:Fluoroscopy; D006801:Humans; D007404:Intervertebral Disc Chemolysis / Q000009:adverse effects; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging / Q000188:drug therapy; D014057:Tomography, X-Ray Computed
chemical_list: D002917:Chymopapain